Safety Of Dupilumab In Moderate-To-Severe Atopic Dermatitis: Clinical Laboratory Results From Three Phase 3 Clinical Trials (Liberty Ad: Solo 1, Solo 2 And Chronos)A. Wollenberg,A. Blauvelt,E. L. Simpson,Z. Chen,B. Shumel,F. A. Khokhar,T. Hultsch,E. Rizova,A. Rossi,N. M. H. Graham,G. Pirozzi, Y. Lu,M. ArdeleanuALLERGY(2018)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要